Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks

Clinical trial NCT04253132 · UNKNOWN

Trial details

NCT number: NCT04253132
Sponsor: NeuroTau, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy

Start date: 2021-01-01
Primary completion: 2022-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.